Literature DB >> 15098086

Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin.

Dierk Thomas1, Anna-Britt Wimmer, Kezhong Wu, Bettina C Hammerling, Eckhard K Ficker, Yuri A Kuryshev, Johann Kiehn, Hugo A Katus, Wolfgang Schoels, Christoph A Karle.   

Abstract

Human ether-a-go-go-related gene (HERG) potassium channels are expressed in multiple tissues including the heart and adenocarcinomas. In cardiomyocytes, HERG encodes the alpha-subunit underlying the rapid component of the delayed rectifier potassium current, I(Kr), and pharmacological reduction of HERG currents may cause acquired long QT syndrome. In addition, HERG currents have been shown to be involved in the regulation of cell proliferation and apoptosis. Selective alpha 1-adrenoceptor antagonists are commonly used in the treatment of hypertension and benign prostatic hyperplasia. Recently, doxazosin has been associated with an increased risk of heart failure. Moreover, quinazoline-derived alpha 1-inhibitors induce apoptosis in cardiomyocytes and prostate tumor cells independently of alpha1-adrenoceptor blockade. To assess the action of the effects of prazosin, doxazosin, and terazosin on HERG currents, we investigated their acute electrophysiological effects on cloned HERG potassium channels heterologously expressed in Xenopus oocytes and HEK 293 cells.Prazosin, doxazosin, and terazosin blocked HERG currents in Xenopus oocytes with IC(50) values of 10.1, 18.2, and 113.2 microM respectively, whereas the IC(50) values for HERG channel inhibition in human HEK 293 cells were 1.57 microM, 585.1 nM, and 17.7 microM. Detailed biophysical studies revealed that inhibition by the prototype alpha 1-blocker prazosin occurred in closed, open, and inactivated channels. Analysis of the voltage-dependence of block displayed a reduction of inhibition at positive membrane potentials. Frequency-dependence was not observed. Prazosin caused a negative shift in the voltage-dependence of both activation (-3.8 mV) and inactivation (-9.4 mV). The S6 mutations Y652A and F656A partially attenuated (Y652A) or abolished (F656A) HERG current blockade, indicating that prazosin binds to a common drug receptor within the pore-S6 region. In conclusion, this study demonstrates that HERG potassium channels are blocked by prazosin, doxazosin, and terazosin. These data may provide a hypothetical molecular explanation for the apoptotic effect of quinazoline-derived alpha1-adrenoceptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098086     DOI: 10.1007/s00210-004-0931-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

Review 1.  Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.

Authors:  Natasha Kyprianou
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

2.  Antiarrhythmic drug carvedilol inhibits HERG potassium channels.

Authors:  C A Karle; V A Kreye; D Thomas; K Röckl; S Kathöfer; W Zhang; J Kiehn
Journal:  Cardiovasc Res       Date:  2001-02-01       Impact factor: 10.787

3.  Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells.

Authors:  Olivia Crociani; Leonardo Guasti; Manuela Balzi; Andrea Becchetti; Enzo Wanke; Massimo Olivotto; Randy S Wymore; Annarosa Arcangeli
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

4.  Use-dependent 'agonist' effect of azimilide on the HERG channel.

Authors:  M Jiang; W Dun; J S Fan; G N Tseng
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

5.  Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.

Authors:  S Zhang; Z Zhou; Q Gong; J C Makielski; C T January
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

6.  A structural basis for drug-induced long QT syndrome.

Authors:  J S Mitcheson; J Chen; M Lin; C Culberson; M C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

7.  Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.

Authors:  N Kyprianou; C M Benning
Journal:  Cancer Res       Date:  2000-08-15       Impact factor: 12.701

8.  Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.

Authors:  José R González-Juanatey; María J Iglesias; Carlos Alcaide; Roberto Piñeiro; Francisca Lago
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

Review 9.  Clinical pharmacokinetics of prazosin.

Authors:  P Jaillon
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

10.  HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium.

Authors:  A Cherubini; G L Taddei; O Crociani; M Paglierani; A M Buccoliero; L Fontana; I Noci; P Borri; E Borrani; M Giachi; A Becchetti; B Rosati; E Wanke; M Olivotto; A Arcangeli
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

View more
  13 in total

1.  Predicting the potency of hERG K⁺ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models.

Authors:  Yayu Tan; Yadong Chen; Qidong You; Haopeng Sun; Manhua Li
Journal:  J Mol Model       Date:  2011-06-10       Impact factor: 1.810

2.  hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine.

Authors:  Ingo Staudacher; Lu Wang; Xiaoping Wan; Sabrina Obers; Wolfgang Wenzel; Frank Tristram; Ronald Koschny; Kathrin Staudacher; Jana Kisselbach; Patrick Koelsch; Patrick A Schweizer; Hugo A Katus; Eckhard Ficker; Dierk Thomas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-12-01       Impact factor: 3.000

Review 3.  Insights into cardio-oncology: Polypharmacology of quinazoline-based α1-adrenoceptor antagonists.

Authors:  Salvatore Patanè
Journal:  World J Cardiol       Date:  2015-05-26

4.  The Effectiveness of Isoplumbagin and Plumbagin in Regulating Amplitude, Gating Kinetics, and Voltage-Dependent Hysteresis of erg-mediated K+ Currents.

Authors:  Linyi Chen; Hsin-Yen Cho; Tzu-Hsien Chuang; Ting-Ling Ke; Sheng-Nan Wu
Journal:  Biomedicines       Date:  2022-03-27

5.  Apoptosis induction by doxazosin and other quinazoline alpha1-adrenoceptor antagonists: a new mechanism for cancer treatment?

Authors:  Natasha Kyprianou; Taylor B Vaughan; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-11       Impact factor: 3.000

6.  Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells.

Authors:  J Jehle; E Ficker; X Wan; I Deschenes; J Kisselbach; F Wiedmann; I Staudacher; C Schmidt; P A Schweizer; R Becker; H A Katus; D Thomas
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

7.  Doxazosin induces apoptosis of cells expressing hERG K+ channels.

Authors:  Dierk Thomas; Ramona Bloehs; Ronald Koschny; Eckhard Ficker; Jaromir Sykora; Johann Kiehn; Kathrin Schlömer; Jakob Gierten; Sven Kathöfer; Edgar Zitron; Eberhard P Scholz; Claudia Kiesecker; Hugo A Katus; Christoph A Karle
Journal:  Eur J Pharmacol       Date:  2007-12-04       Impact factor: 4.432

8.  Global analysis reveals families of chemical motifs enriched for HERG inhibitors.

Authors:  Fang Du; Joseph J Babcock; Haibo Yu; Beiyan Zou; Min Li
Journal:  PLoS One       Date:  2015-02-20       Impact factor: 3.240

9.  Modulation of hERG potassium currents in HEK-293 cells by protein kinase C. Evidence for direct phosphorylation of pore forming subunits.

Authors:  S L Cockerill; A B Tobin; I Torrecilla; G B Willars; N B Standen; J S Mitcheson
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

10.  The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China.

Authors:  Fazhong He; Jianquan Luo; Zhiying Luo; Lan Fan; Yijing He; Dingliang Zhu; Jinping Gao; Sheng Deng; Yan Wang; Yuesheng Qian; Honghao Zhou; Xiaoping Chen; Wei Zhang
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.